Opportunities and challenges of radiotherapy for treating cancer

D Schaue, WH McBride - Nature reviews Clinical oncology, 2015 - nature.com
The past 20 years have seen dramatic changes in the delivery of radiation therapy, but the
impact of radiobiology on the clinic has been far less substantial. A major consideration in …

Recurrent oral cancer: current and emerging therapeutic approaches

SD da Silva, M Hier, A Mlynarek, LP Kowalski… - Frontiers in …, 2012 - frontiersin.org
Oral cavity cancer (OCC) is associated with high incidence of loco-regional recurrences,
which account for the majority of treatment failures post-surgery and radiotherapy. The time …

Hedgehog signaling in prostate cancer and its therapeutic implication

A Gonnissen, S Isebaert, K Haustermans - International journal of …, 2013 - mdpi.com
Activation of Hedgehog (Hh) signaling is implicated in the development and progression of
several tumor types, including prostate cancer, which is still the most common non-skin …

EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection

KC Cuneo, MK Nyati, D Ray, TS Lawrence - Pharmacology & therapeutics, 2015 - Elsevier
The epidermal growth factor receptor (EGFR) plays an important role in tumor progression
and treatment resistance for many types of malignancies including head and neck …

Stimuli-Responsive Peptide/siRNA Nanoparticles as a Radiation Sensitizer for Glioblastoma Treatment by Co-Inhibiting RELA/P65 and EGFR

B Cen, J Zhang, X Pan, Z Xu, R Li, C Chen… - International Journal …, 2024 - Taylor & Francis
Purpose To develop a novel approach for increasing radiosensitivity in glioblastoma (GBM)
by using targeted nanoparticles to deliver siRNA aimed at silencing the EGFR and …

Radiation-induced Notch signaling in breast cancer stem cells

C Lagadec, E Vlashi, Y Alhiyari, TM Phillips… - International Journal of …, 2013 - Elsevier
Purpose To explore patterns of Notch receptor and ligand expression in response to
radiation that could be crucial in defining optimal dosing schemes for γ-secretase inhibitors if …

The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies

M Grade, HA Wolff, J Gaedcke, BM Ghadimi - Langenbeck's archives of …, 2012 - Springer
Introduction Preoperative chemoradiotherapy represents the standard treatment for patients
with locally advanced rectal cancer. Unfortunately, the response of individual tumors to …

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

G Gasparini, F Torino, T Ueno, S Cascinu, T Troiani… - Angiogenesis, 2012 - Springer
Purpose To assess safety and activity of neoadjuvant bevacizumab, capecitabine and
standard radiotherapy in locally advanced rectal cancer as well as potential predictive …

Publication trends and knowledge maps of global translational medicine research

FC Ma, PH Lyu, Q Yao, L Yao, SJ Zhang - Scientometrics, 2014 - Springer
Translational medical research literatures have increased rapidly in last decades and there
have been fewer attempts or efforts to map global research context of translational medical …

Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy

G Spolverato, S Pucciarelli, R Bertorelle, A De Rossi… - Cancers, 2011 - mdpi.com
Locally advanced rectal cancer is currently treated with pre-operative radiochemotherapy
(pRCT), but the response is not uniform. Identification of patients with higher likelihood of …